A Spectral-Domain-OCT-Guided One-Year Follow-Up of Newly Diagnosed Pediatric Idiopathic Intracranial Hypertension

Yuval Cohen1,2,3, Michael Eidel4, Aviv Vidan1,2

  • 1Department of Ophthalmology, Ziv Medical Center, Safed 1311001, Israel.

PubMed

Insights

Pediatric idiopathic intracranial hypertension (IIH) patients showed initial retinal nerve fiber layer thickness (RNFLT) thickening that resolved by three months. Segmental analysis revealed persistent nasal RNFLT thinning one year after diagnosis.

Area of Science:

  • Ophthalmology
  • Neurology
  • Pediatrics

Background:

  • Idiopathic intracranial hypertension (IIH) is a condition causing increased intracranial pressure in children.
  • Longitudinal changes in retinal nerve fiber layer thickness (RNFLT) in pediatric IIH are not well understood.
  • Spectral-Domain Optical Coherence Tomography (SD-OCT) offers a non-invasive method to assess optic nerve health.

Purpose of the Study:

  • To evaluate longitudinal changes in RNFLT in newly diagnosed pediatric IIH patients.
  • To compare RNFLT in IIH patients with a healthy control group over one year.
  • To assess the utility of SD-OCT in monitoring pediatric IIH.

Main Methods:

  • Prospective observational cohort study with cross-sectional control group comparison.
  • Included 19 children with IIH and 25 healthy controls (aged 7-17).
  • SD-OCT was used to measure RNFLT, total retinal thickness, and optic disk area at baseline and at multiple follow-up points up to 12 months.

Main Results:

  • Baseline RNFLT was significantly higher in the IIH group (133.1 µm) compared to controls (113.1 µm).
  • RNFLT thickening in the IIH group resolved by the 3-month follow-up.
  • Segmental RNFL analysis showed significant thinning in nasal segments at 1 year, and two patients had superior quadrant thinning.

Conclusions:

  • SD-OCT is a valuable non-invasive tool for diagnosing and monitoring pediatric IIH.
  • RNFL thickening typically resolves within 3 months of IIH diagnosis.
  • Further research with larger cohorts is needed to investigate long-term segmental RNFL changes and potential axonal damage.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
247
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
311
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.3K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.7K